10-Q: Genworth Reports Mixed Q3, Advances CareScout & Share Buybacks

Genworth Financial reports increased net income for Q3 2025 but a decline in adjusted operating income, while making significant strides in its CareScout growth initiatives and share repurchase program.

Summary

• Net income available to common stockholders increased by 36% to $116 million for the three months ended September 30, 2025, compared to $85 million in the prior year period.
• Adjusted operating income available to common stockholders decreased by 65% to $17 million for the three months ended September 30, 2025, down from $48 million in the prior year period.
• For the nine months ended September 30, 2025, net income available to common stockholders decreased by 26% to $221 million, from $300 million in the prior year period.
• Adjusted operating income available to common stockholders for the nine months ended September 30, 2025, decreased by 47% to $136 million, from $258 million in the prior year period.
• Total assets increased by $1,615 million to $88,486 million as of September 30, 2025, from $86,871 million at December 31, 2024.
• Total equity increased by $390 million to $9,821 million as of September 30, 2025, from $9,431 million at December 31, 2024.
• A new share repurchase program of up to $350 million was authorized on September 18, 2025, with approximately $325 million remaining as of October 31, 2025, after finalizing the previous authorization.
• Enact Holdings provided $110 million in capital returns to Genworth Holdings in Q3 2025, comprising $85 million in share repurchases and $25 million in quarterly dividends.
• The cumulative economic benefit of approved rate actions in the long-term care insurance multi-year in-force rate action plan since 2012 through Q3 2025 is estimated at $31.8 billion on a net present value basis.
• CareScout Services expanded its network to over 700 home care providers with more than 950 locations and acquired Seniorly on October 31, 2025, to expand into assisted living and direct-to-consumer markets.
• CareScout Insurance launched its individual long-term care insurance product, CareScout Care Assurance, in October 2025, approved in 37 states.
• Moodys upgraded Genworth Holdings' senior unsecured debt to Baa3 from Ba1 and Enact Mortgage Insurance Corporation (EMICO) to A2 from A3 on August 6, 2025, both with a stable outlook.
• A.M. Best revised the outlook to positive from stable for Genworth Life Insurance Company and Genworth Life Insurance Company of New York (C++ affirmed) and EMICO (Aaffirmed) in September 2025.
• Enact's PMIERs sufficiency ratio was 162%, or $1,904 million above requirements, as of September 30, 2025.
• Genworth Holdings had $254 million of unrestricted cash and cash equivalents as of September 30, 2025, including $145 million held for future obligations.

Sentiment

Score: 5

Explanation: The filing presents a mixed financial picture with a notable decline in adjusted operating income, a key management metric, and persistent losses in the Long-Term Care segment. However, strong capital management, significant share repurchases, positive credit rating actions, and promising strategic advancements in the CareScout business provide a counterbalance. The potential for a large litigation recovery offers a significant upside, but its realization is uncertain due to an ongoing appeal. The overall sentiment is neutral, reflecting a company in transition, actively managing legacy challenges while investing in future growth and returning capital to shareholders.

Positives

• Net income available to common stockholders increased by 36% to $116 million for Q3 2025, compared to $85 million in Q3 2024.
• Basic and diluted net income per share increased by $0.09 and $0.09 respectively for Q3 2025.
• Total equity increased by $390 million to $9,821 million as of September 30, 2025, driven by net income and unrealized gains on investments.
• A new $350 million share repurchase program was authorized, demonstrating commitment to returning capital to shareholders.
• Enact Holdings provided $110 million in capital returns to Genworth Holdings in Q3 2025, including $85 million from share repurchases and $25 million in dividends.
• The cumulative economic benefit of approved rate actions in the long-term care insurance business reached approximately $31.8 billion (NPV basis) through Q3 2025.
• CareScout Services significantly expanded its network to over 700 home care providers and acquired Seniorly to accelerate direct-to-consumer market entry.
• CareScout Insurance successfully launched its individual long-term care insurance product, CareScout Care Assurance, approved in 37 states.
• Moodys upgraded Genworth Holdings' senior unsecured debt to Baa3 and EMICO's financial strength rating to A2, both with stable outlooks.
• A.M. Best revised the outlook to positive for Genworth Life Insurance Company, Genworth Life Insurance Company of New York, and EMICO, affirming their financial strength ratings.
• Enact's PMIERs sufficiency ratio remains strong at 162%, exceeding requirements by $1,904 million.
• A U.K. High Court judgment in favor of AXA in the Santander litigation could entitle Genworth to recover approximately $750 million, pending appeal.

Negatives

• Adjusted operating income decreased by 65% to $17 million for Q3 2025, from $48 million in Q3 2024.
• Adjusted operating income for the nine months ended September 30, 2025, decreased by 47% to $136 million, from $258 million in the prior year period.
• The Long-Term Care Insurance segment's adjusted operating loss increased significantly by 117% to $100 million in Q3 2025, primarily due to unfavorable cash flow assumption updates.
• The Long-Term Care Insurance segment's adjusted operating loss increased by 132% to $167 million for the nine months ended September 30, 2025, due to unfavorable assumption updates and non-recurring insurance recoveries in the prior year.
• Enact segment's adjusted operating income decreased by 9% in Q3 2025 and 8% for the nine months, primarily due to lower reserve releases and higher new delinquencies.
• Net investment income decreased by 1% for the nine months ended September 30, 2025, primarily due to lower policy loan rates and amortization of cash flow hedges.
• Loss from discontinued operations, net of taxes, increased to $8 million in Q3 2025 from $3 million in Q3 2024, and to $20 million for the nine months from $5 million.
• The change in the discount rate used to measure future policy benefits and related reinsurance recoverables decreased total equity by $880 million for the nine months ended September 30, 2025.
• Commercial mortgage loans, net, decreased by $96 million from December 31, 2024, to September 30, 2025, due to payments outpacing originations.

Risks

• Inability to successfully launch new lines of business, including long-term care insurance and other products and services with CareScout.
• Failure to maintain the self-sustainability of legacy U.S. life insurance subsidiaries, potentially due to the inability to achieve desired levels of in-force rate actions or delays in future premium rate increases.
• Inaccuracies or changes in estimates, assumptions, methodologies, valuations, projections, and/or models, which could result in inadequate reserves or other adverse financial results.
• Impact on holding company liquidity caused by an inability to receive dividends or other returns of capital from Enact Holdings, and limited sources of capital and financing.
• The potential recovery in the AXA and Santander litigation may be impacted by a successful appeal, significant delays, or other adverse developments.
• Adverse changes to the structure or requirements of Federal National Mortgage Association (Fannie Mae), Federal Home Loan Mortgage Corporation (Freddie Mac), or the U.S. mortgage insurance market.
• An increase in the number of loans insured through federal government mortgage insurance programs, such as those offered by the Federal Housing Administration (FHA).
• The inability of Enact Holdings and/or its U.S. mortgage insurance subsidiaries to continue to meet the Private Mortgage Insurer Eligibility Requirements (PMIERs) or minimum statutory capital requirements.
• Changes in economic, market, and political conditions, labor shortages, fluctuating interest rates, and continued inflationary pressure.
• Downgrades in financial strength and credit ratings, which could adversely impact liquidity.
• Counterparty credit risks, including defaults by counterparties to reinsurance arrangements or derivative instruments.
• Litigation and regulatory investigations or other actions, including commercial and contractual disputes with counterparties.
• The inability to effectively manage information technology systems, cyber incidents, or other failures, disruptions, or security breaches.

Future Outlook

Management expects quarterly adverse variances between actual and expected experience to persist, potentially leading to future remeasurement losses in the long-term care insurance business. The company anticipates continued capital returns from Enact Holdings to fund strategic initiatives, share repurchases, and opportunistic debt reduction. Future product offerings for CareScout Insurance are expected to include an asset-based hybrid long-term care insurance design and worksite/association group offerings. The company plans to invest approximately $45 million to $50 million in CareScout Services for the full year 2025, excluding the Seniorly acquisition. The initial capital investment of $85 million in CareScout Insurance is expected to be the majority of funding over the next few years. The resolution of the AXA and Santander litigation appeal could result in a recovery of approximately $750 million, which would be deployed in line with capital allocation priorities: CareScout investments, share repurchases, and debt reduction. The company will complete its annual review of cash flow assumptions for all insurance products in Q4 2025, with potential impacts on reserve levels and earnings, particularly for capped cohorts. Overall claims costs in the long-term care insurance business are expected to continue increasing as blocks age, while renewal premiums are expected to decline over time, partially offset by future approved rate actions.

Management Comments

• We continue to create shareholder value through Enact's growing market value and capital returns.
• Capital returns from Enact will continue to benefit our shareholders by funding our strategic initiatives, including new CareScout products and services, as well as share repurchases and opportunistic debt reduction.
• We continue to make progress on our strategic priority to maintain self-sustaining, customer-centric legacy U.S. life insurance subsidiaries.
• Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business.
• We continue to drive future growth through CareScout with innovative, consumer-focused aging care services and funding solutions.
• The acquisition of Seniorly will expand the CareScout Quality Network to include assisted living communities and is expected to accelerate our expansion into the direct-to-consumer market.
• We believe this strong strategic and cultural alignment positions CareScout Services for continued growth and leadership as we build a trusted aging-care platform.
• We continue to expect to invest approximately $45 million to $50 million in CareScout Services for the full year 2025, excluding our payment to acquire Seniorly.
• We anticipate this initial capital investment of $85 million in CareScout Insurance will be the majority of the funding we allocate to this business over the next few years.
• We believe our investments in CareScout Services and CareScout Insurance will drive sustainable future growth for Genworth and are aligned with our overarching priority to maximize long-term value for our shareholders.
• We will continue to strive to maintain a disciplined approach in our capital allocation strategy, balancing investments in CareScout growth initiatives with returning value to shareholders and opportunistically retiring debt.
• We expect to deploy any loss recoveries from the AXA/Santander litigation in line with our stated capital allocation priorities, which are investing in growth through CareScout, returning cash to shareholders through our share repurchase program and opportunistically paying down debt.

Industry Context

The U.S. economy experienced significant volatility and uncertainty in the first three quarters of 2025, marked by changing economic policies, inflationary pressures (Consumer Price Index up 3.0% year-over-year in September 2025), and elevated mortgage rates. Housing affordability deteriorated, though it eased slightly in Q3 2025 as mortgage rates declined and home price growth slowed. The private mortgage insurance industry remains highly competitive, with regulatory developments like the FHFA's acceptance of VantageScore 4.0 potentially impacting market dynamics. The long-term care insurance industry continues to face challenges from higher benefit utilization and cost of care inflation, necessitating ongoing in-force rate actions. The life and annuities segments are in runoff, with results primarily influenced by mortality, persistency, and interest rate movements. The aging population trend supports the strategic focus on aging care services through CareScout.

Comparison to Industry Standards

• Enact's PMIERs sufficiency ratio of 162% ($1,904 million above requirements) indicates strong capital positioning relative to regulatory standards for private mortgage insurers, which is crucial for eligibility with government-sponsored enterprises like Fannie Mae and Freddie Mac.
• The U.S. domiciled life insurance subsidiaries' consolidated risk-based capital ratio of approximately 303% (company action level basis) is a key regulatory metric, and while slightly down from 306%, it remains well above typical minimums, suggesting a healthy capital buffer compared to industry peers.

Legal Proceedings

• TVPX ARS, INC. v. GLAIC: Putative class action alleging unlawful and excessive cost of insurance charges. Eleventh Circuit affirmed district court's denial of Genworth's motions; plaintiff refiled complaint in Eastern District of Virginia, with trial scheduled for late April 2026.
• Burkhart et al. v. Genworth Financial et al.: Putative class action alleging intentional and constructive fraudulent transfer by GLIC. Genworth filed a motion for summary judgment, which plaintiffs opposed.
• Trauernicht et al v. Genworth Financial: Putative class action alleging breach of fiduciary duties under ERISA regarding BlackRock Target Date Funds in the Savings Plan. Case certified as a class action, Genworth's summary judgment motion denied, and an appeal to the Fourth Circuit was granted, with oral argument on October 21, 2025.
• M/O Arbitration Between Blue Cross Blue Shield Nebraska and GLIC: Arbitration regarding BCBSNE's intent to recapture a block of long-term care insurance policies. Arbitration panel issued a final decision on May 19, 2025, resulting in a $24 million payment to BCBSNE and a $26 million pre-tax gain for Genworth.
• In Re MOVEit Customer Data Security Breach Litigation: Putative class action lawsuits related to a data security event involving the MOVEit file transfer system used by a third-party vendor. Most causes of action against Genworth were dismissed, retaining claims for common law negligence, breach of implied contract, and a Massachusetts statutory violation. Genworth moved for partial reconsideration on September 9, 2025.
• Fox v. GLAIC: Putative class action alleging wrongful termination of California life insurance policies. Genworth's motion to strike class allegations and plaintiff's motion to remand were denied; plaintiff's appeal was dismissed.
• Kaplan v. GLIC: Putative class action alleging misrepresentation and inadequate disclosure regarding pricing structure and rate increases for My Future My Plan 2 series of long-term care insurance policies. Genworth moved to dismiss the complaint.

Related Party Transactions

• Enact Holdings, a consolidated subsidiary, provided $110 million of capital returns to Genworth Holdings in Q3 2025, comprising $85 million of share repurchases and $25 million of quarterly dividends. For the nine months ended September 30, 2025, Genworth Holdings received $280 million of capital returns from Enact Holdings.

Stakeholder Impact

• Shareholders: Benefit from ongoing share repurchase programs (new $350 million authorization) and potential significant recovery from the AXA/Santander litigation (~$750 million), but face risks from declining adjusted operating income and persistent losses in legacy businesses.
• Policyholders (Long-Term Care): Continue to be impacted by in-force rate actions and associated benefit reductions, but may benefit from CareScout Quality Network discounts on care costs.
• Customers (CareScout): Gain access to an expanded network of home care and assisted living providers, new services like Care Plans, and innovative long-term care insurance products.
• Employees: Face potential impacts from ongoing efforts to manage operating costs, but also benefit from investments in growth initiatives like CareScout.
• Creditors: Benefit from credit rating upgrades (Moodys) and positive outlook revisions (A.M. Best) for Genworth Holdings and its insurance subsidiaries, indicating improved financial strength, but face risks from ongoing litigation and macroeconomic volatility.

Next Steps

• Complete the required annual review of cash flow assumptions for long-term care insurance products in Q4 2025.
• Complete statutory cash flow testing for life insurance companies in Q4 2025.
• Launch an in-person evaluation option for the Care Plans product in Q4 2025.
• Expand the range of services offered by CareScout Services and the number of customers served over time.
• Develop future product offerings for CareScout Insurance, including an asset-based hybrid long-term care insurance design and worksite/association group offerings.
• Continue to vigorously defend against ongoing legal proceedings, including TVPX ARS, INC. v. GLAIC (trial late April 2026), Burkhart et al. v. Genworth Financial et al., Trauernicht et al v. Genworth Financial (appeal oral argument Oct 21, 2025), In Re MOVEit Customer Data Security Breach Litigation (motion for partial reconsideration Sep 9, 2025), Fox v. GLAIC, and Kaplan v. GLIC.
• Monitor macroeconomic trends, including inflation and tariff negotiations, to mitigate potential adverse impacts to liquidity.
• Deploy any loss recoveries from the AXA and Santander litigation in line with capital allocation priorities: CareScout investments, share repurchases, and opportunistic debt reduction.

Key Dates

Recommendation

Genworth Financial presents a mixed financial performance, with a notable decline in adjusted operating income, which management uses to assess core performance, and ongoing challenges in its legacy Long-Term Care Insurance segment. However, the company is actively executing a robust capital management strategy, including significant share repurchases and capital returns from its Enact segment. Strategic investments in the CareScout growth initiatives are progressing well, with new product launches and acquisitions aimed at future revenue streams. The potential for a substantial recovery from the AXA/Santander litigation, while subject to appeal, represents a significant upside. Given the balance of persistent operational headwinds in legacy businesses against strong capital allocation, strategic growth, and potential litigation upside, a 'Hold' recommendation is appropriate for a seasoned investor. The stock is in a transitional phase, and while there are clear positive developments, the core profitability metrics require further improvement to warrant a stronger buy signal.

Keywords

Mortgage Insurance, Long-Term Care Insurance, Life Insurance, Annuities, SEC Filing, Financial Results, Share Repurchase, Capital Returns, CareScout, Financial Ratings, PMIERs, Investment Portfolio, Derivative Instruments, Litigation, Insurance Reserves